Variation name (cDNA level) | Variation name (protein level) | Variation status | Variation class |
c.IVS2+1G>A (c.247+1G>A) | Heterozygous | Mutation |
wt codon | wt aa | mutant codon | mutant aa | mutational event | mutation type |
CCC | Pro | spl+1 | Spl. | G->A | Ts |
Structure | Key Residue (HCD) | Pyrimidin doublet | CpG |
EGF-like #01 |
At the mRNA level | On restriction map |
Skipping of exon 2, frameshift | New restriction site(s): none Lost restriction site(s): none |
Impact on splicing | ||||||||||
Splice site type | Wild type sequence | CV | Mutant type sequence | CV | Variation (%) | |||||
TCCgtaagt |
| TCCataagt |
| -32.6 % |
Sample ID | Patient status | Gender | Transmission | Age of onset | Age of death | Geographic origin |
FRA01BOU F0451 I0488 | Proband | Male | familial | FRANCE |
Phenotypic group | Disease |
NA | Classical MFS |
Symptom |
Reference ID | PubMed ID | Reference |
207 | - | Boileau C. (personnal communication 2013) |